Skip to main content Accessibility help
×
Home

New insights into the role of the GABAA–benzodiazepine receptor in psychiatric disorder

  • David J. Nutt (a1) and Andrea L. Malizia (a1)

Abstract

Background

In the 40 years since the first benzodiazepine was brought into clinical use there has been a substantial growth in understanding the molecular basis of action of these drugs and the role of their receptors in disease states.

Aims

To present current knowledge about the role of the GABAA–benzodiazepine receptor in anxiety disorders, new insights into the molecular biology of the receptor complex and neuroimaging studies suggesting involvement of these receptors in disease states.

Method

An overview of published literature, including some recent data.

Results

The molecular biology of this receptor is detailed. Molecular genetic studies suggesting involvement of the GABAA–benzodiazepine receptor in animal behaviour and learning are outlined; possible parallels with human psychopathology are discussed.

Conclusions

Current insights into the role of the GABAA–benzodiazepine receptor in the action of benzodiazepines and as a factor in disease states, in both animals and humans, may lead to new, more sophisticated interventions at this receptor complex and potentially significant therapeutic gains.

Copyright

Corresponding author

D. J. Nutt, Psychopharmacology Unit, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 ITD, UK. Tel: 0117 925 3066; fax: 0117 927 7057; e-mail: David. J. Nutt@bristol.ac.uk

Footnotes

Hide All

Declaration of interest

D. J. N. has received grants from various pharmaceutical companies with an interest in drugs acting at the GABA–benzodiazepine receptor.

Footnotes

References

Hide All
Barnard, E. A., Skolnick, P., Olsen, R. W., et al (1998) International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of subunit structure and receptor function. Pharmacological Reviews, 50, 291313.
Braestrup, C., Nielsen, M. & Olsen, C. E. (1980) Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proceedings of the National Academy of Sciences of the USA, 77, 22882292.
Cossar, J. A., Hayes, P. C. & O'Carroll, R. E. (1997) Benzodiazepine-like substances and hepatic encephalopathy. Implications for treatment. CNS Drugs, 8, 91101.
Crestani, F., Lorez, M., Baer, K., et al (1999) Decreased GABAA–receptor clustering results in enhanced anxiety and a bias for threat cues. Nature Neuroscience, 2, 833839.
Davies, M., Bateson, A. N. & Dunn, S. M. J. (1998) Structural requirements for ligand interactions at the benzodiazepine recognition site of the GABA(A) receptor. Journal of Neurochemistry, 70, 21882194.
Doble, A. (1999) New insights into the mechanism of action of hypnotics. Journal of Psychopharmacology, 13 (suppl. 1), S11S20.
Glover, V. (1998) Function of endogenous monoamine oxidase inhibitors (tribulin). Journal of Neural Transmission, suppl. 52, 307313.
Goddard, A. W., Mason, G. F., Almai, A., et al (2001) Reductions in occipital cortex GABA levels in panic disorder detected with IH–magnetic resonance spectroscopy. Archives of General Psychiatry, 58, 556561.
Haefely, W. E. (1978) Central action of benzodiazepines: general introduction. British Journal of Psychiatry, 133, 231238.
Holt, R. A., Bateson, A. N. & Martin, I. L. (1999) Chronic treatment with diazepam or abecarnil differentially affects the expression of GABAA receptor subunit mRNAs in the rat cortex. Neuropharmacology, 35, 14571463.
Hucklebridge, F., Doyle, A., Pang, F., et al (1998) Regional and molecular separation of the four bioactivities of ‘tribulin’. Neuroscience Letters, 240, 2932.
Kalueff, A. & Nutt, D. J. (1997) Role of GABA in memory and anxiety. Depression and Anxiety, 4, 100110.
Lingford-Hughes, A., Hume, S. P., Feeney, A., et al (2001) Imaging the α5–subunit containing GABA–benzodiazepine receptor subtype in vivo with PET. (Presented at the British Association of Psychopharmacology annual meeting, Harrogate.) Journal of Psychopharmacology, in press.
Little, H. T., Gale, R., Sellars, N., et al (1988) Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142. Neuropharmacology, 27, 383–381.
Low, K., Crestani, F., Keist, R., et al (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science, 290, 131134.
Maddock, R. J. (1998) Acute effects of low dose flumazenil in panic disorder. Journal of Clinical Psychopharmacology, 18, 258261.
Malizia, A. L. (1999) What do brain imaging studies tell us about anxiety disorders? Journal of Psychopharmacology, 13, 372378.
Malizia, A. L. (2000) Positron emitting ligands in the study of the clinical psychopharmacology of anxiety and anxiety disorders. MD thesis, Faculty of Medicine, University of Bristol, UK.
Malizia, A. L., Cunningham, V. J., Bell, C. M., et al (1998) Decreased brain GABAA–benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Archives of General Psychiatry, 55, 715720.
Nayeem, N., Green, T. P., Martin, J. L., et al (1994) Quaternary structure of the native GABAA receptor determined by electron microscopic image analysis. Journal of Neurochemistry, 62, 815818.
Nielsen, M., Braestrup, C. & Squires, R. F. (1978) Evidence for a late evolutionary appearance of brain-specific benzodiazepine receptors: an investigation of 18 vertebrate and 5 invertebrate species. Brain Research, 141, 342346.
Nutt, D. J., Glue, P., Lawson, C. W., et al (1990) Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorders. Archives of General Psychiatry, 47, 917925.
Roy-Byrne, P. P., Cowley, D. S., Greenblatt, D. J., et al (1990) Reduced benzodiazepine sensitivity in panic disorder. Archives of General Psychiatry, 47, 534538.
Rudolph, U., Crestani, F., Benke, D., et al (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid (A) receptor subtypes. Nature, 401, 796800.
Sangameswaran, L., Fales, H. M., Friedrich, P., et al (1986) Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in the human brain. Proceedings of the National Academy of Sciences of the USA, 83, 92369241.
Schofield, P. R., Darlison, M. G., Fujita, N., et al (1987) Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family. Nature, 328, 221227.
Schuckit, M. A., Mazzanti, C., Smth, T. I., et al (1999) Selective genotyping for the role of 5-HT2C and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study. Biological Psychiatry, 45, 647651.
Strohle, A., Kellner, M., Holsboer, F., et al (1999) Behavioural, neuroendocrine and cardiovascular response to flumazenil: no evidence for altered benzodiazepine sensitivity in panic disorder. Biological Psychiatry, 45, 321326.
Tinuper, P., Montagna, P., Plazzi, G., et al (1994) Idiopathic recurring stupor. Neurology, 44, 621625.
Tiihonen, J., Kuikka, J., Rasanen, P., et al (1997) Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Molecular Psychiatry, 6, 463471.
Tobler, I., Kopp, C., Deboer, T., et al (2001) Diazepam-induced changes in sleep: role of the al GABAA receptor subtype. Proceedings of the National Academy of Sciences of the USA, 98, 64646469.
Westh-Hansen, S. E., Rasmussen, P. B., Hastrup, S., et al (1997) Decreased agonist sensitivity of human GABA(A) receptors by an amino acid variant, isoleucine to valine, in the alpha I subunit. European Journal of Pharmacology, 329, 253257
Woods, S. W., Charney, D. S., Silver, J. M., et al (1991) Behavioural, biochemical, cardiovascular responses to the benzodiazepine receptor antagonist flumazenil. Psychiatry Research, 36, 115127.
Williams, D. D. R. & McBride, A. (1998) Benzodiazepines: time for reassessment. British Journal of Psychiatry, 173, 361362.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

New insights into the role of the GABAA–benzodiazepine receptor in psychiatric disorder

  • David J. Nutt (a1) and Andrea L. Malizia (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *